The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pfizer Inc. (“Pfizer” or “the Company”) (NYSE: PFE) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Pfizer is the subject of a report published by Bloomberg on October 26, 2022. According to the report, the Company is under investigation by Italian officials who claim that it hid at least 1.2 billion euros in profit through a scheme of transferring money to avoid paying taxes in the country. The probe reportedly began earlier in 2022 and covers a period of time from 2017 to 2019.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at email@example.com.
The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.